LunGuard

Reflux Prevention Device for Ventilated and Tube-fed Patients

Health Tech & Life Sciences
Non Active, Dec 2020 ceased to operate
Seed Yavne Founded 2009
LinkedIn
Total raised
$600K
Last: Seed 2009-01
Stage
Seed
Founded
2009
Headcount
1-10
HQ
Yavne
Sector
Health Tech & Life Sciences

About

LunGuard is developing a proprietary physiological integrated patient interface system for ICU ventilated and fed patients. Its technology pipeline is built around the Reflux Prevention System (RPS technology). The system incorporates six active safety and efficient features: an intelligent reflux prevention system to safely reduce VAP; it enables more aggressive ventilation and nutrition therapy; a smart system for ETT cuff sealing monitoring and control to reduce aspiration; it enhances patient safety by the integrated pulmonary pressure detector and enables more effective ventilation of obese and asthma patients; the Smart Tube which incorporates PH sensors that serve as a reflux episode indicator; and a Vomiting indicator based on pressure technique. The system can be used with any ventilator or feeding system and replaces the NG tube with its own proprietary smart sensor. The Reflux Prevention feature is capable of managing reflux, reducing pulmonary aspiration and significantly lowering the occurrence of Ventilator Associated Pneumonia (VAP) in ventilated patients.

Funding history · 1 round · $600K total

2009-01
Seed $600K

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Sensing
Target customers
ConsumersDemographics & FamilyBabiesHealthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 Patents

Tags

preventionmedical-devicesrespiratoryhospitalsventilationfeedingsensorspulmonary